BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8822941)

  • 21. Disruption of the multiple tumor suppressor gene MTS1/p16(INK4a)/CDKN2 by illegitimate V(D)J recombinase activity in T-cell acute lymphoblastic leukemias.
    Cayuela JM; Gardie B; Sigaux F
    Blood; 1997 Nov; 90(9):3720-6. PubMed ID: 9345058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions.
    Yoshioka M; O'Neill JP; Vacek PM; Finette BA
    Cancer Res; 2001 Apr; 61(8):3432-8. PubMed ID: 11309304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of mutations in the human HPRT gene.
    Keohavong P; Xi L; Grant SG
    Methods Mol Biol; 2014; 1105():291-301. PubMed ID: 24623237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.
    Messier TL; O'Neill JP; Hou SM; Nicklas JA; Finette BA
    EMBO J; 2003 Mar; 22(6):1381-8. PubMed ID: 12628930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular nature of spontaneous mutations at the hypoxanthine-guanine phosphoribosyltransferase (hprt) locus in Chinese hamster ovary cells.
    Xu Z; Yu Y; Schwartz JL; Meltz ML; Hsie AW
    Environ Mol Mutagen; 1995; 26(2):127-38. PubMed ID: 7556109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPRT gene alterations in umbilical cord blood T-lymphocytes in newborns of mothers exposed to tobacco smoke during pregnancy.
    Keohavong P; Xi L; Day RD; Zhang L; Grant SG; Day BW; Ness RB; Bigbee WL
    Mutat Res; 2005 May; 572(1-2):156-66. PubMed ID: 15790499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients.
    Laquerbe A; Sala-Trepat M; Vives C; Escarceller M; Papadopoulo D
    Mutat Res; 1999 Dec; 431(2):341-50. PubMed ID: 10635999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleotide sequence analysis of human hypoxanthine phosphoribosyltransferase (HPRT) gene deletions.
    Monnat RJ; Hackmann AF; Chiaverotti TA
    Genomics; 1992 Jul; 13(3):777-87. PubMed ID: 1639404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel types of mutation identified at the hprt locus of human T-lymphocytes.
    Hou SM
    Mutat Res; 1994 Jul; 308(1):23-31. PubMed ID: 7516483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies.
    Zhang M; Swanson PC
    J Biol Chem; 2008 Mar; 283(11):6717-27. PubMed ID: 18187418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
    Fuscoe JC
    Methods Mol Biol; 2005; 291():171-8. PubMed ID: 15502222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Analysis of Mutations in the Human HPRT Gene.
    Keohavong P; Xi L; Grant SG
    Methods Mol Biol; 2020; 2102():349-359. PubMed ID: 31989566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity.
    Aplan PD; Lombardi DP; Ginsberg AM; Cossman J; Bertness VL; Kirsch IR
    Science; 1990 Dec; 250(4986):1426-9. PubMed ID: 2255914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V(D)J recombination in ataxia telangiectasia, Bloom's syndrome, and a DNA ligase I-associated immunodeficiency disorder.
    Hsieh CL; Arlett CF; Lieber MR
    J Biol Chem; 1993 Sep; 268(27):20105-9. PubMed ID: 8397200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.
    Murray JM; O'Neill JP; Messier T; Rivers J; Walker VE; McGonagle B; Trombley L; Cowell LG; Kelsoe G; McBlane F; Finette BA
    J Immunol; 2006 Oct; 177(8):5393-404. PubMed ID: 17015725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression.
    Hashimoto H; Chatterjee S; Berger NA
    Cancer Res; 1995 Sep; 55(18):4029-35. PubMed ID: 7664276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke.
    Finette BA; O'Neill JP; Vacek PM; Albertini RJ
    Nat Med; 1998 Oct; 4(10):1144-51. PubMed ID: 9771747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of hprt mutants induced by 2-cyanoethylene oxide in human lymphoblastoid cells.
    Recio L; Simpson D; Cochrane J; Liber H; Skopek TR
    Mutat Res; 1990 Nov; 242(3):195-208. PubMed ID: 2270092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. V(D)J recombination activity in human hematopoietic cells: correlation with developmental stage and genome stability.
    Gauss GH; Domain I; Hsieh CL; Lieber MR
    Eur J Immunol; 1998 Jan; 28(1):351-8. PubMed ID: 9485214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
    Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.